EP 1631311 A2 20060308 - HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE
Title (en)
HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE
Title (de)
HUMANISIERTE ANTI-CCR2-ANTIKÖRPER UND ANWENDUNGSVERFAHREN
Title (fr)
ANTICORPS HUMANISES ANTI-CCR2 ET LEURS PROCEDES D'UTILISATION
Publication
Application
Priority
US 0339599 W 20031210
Abstract (en)
[origin: WO2005060368A2] The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR2 with a ligand thereof, and to use of the antibodies and fragments in therapeutic, prophylactic and diagnostic methods.
IPC 1-7
IPC 8 full level
A61K 39/395 (2006.01); C07K 16/28 (2006.01)
CPC (source: EP)
A61P 9/10 (2017.12); A61P 29/00 (2017.12); A61P 31/18 (2017.12); A61P 37/06 (2017.12); C07K 16/2866 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/71 (2013.01); C07K 2317/76 (2013.01); C07K 2319/00 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005060368 A2 20050707; WO 2005060368 A3 20051222; AU 2003300896 A1 20050714; CA 2529694 A1 20050707; EP 1631311 A2 20060308; EP 1631311 A4 20070411; EP 2135619 A1 20091223; IL 172533 A0 20060410; IL 172533 A 20120229; JP 2007521248 A 20070802; MX PA06000176 A 20060627
DOCDB simple family (application)
US 0339599 W 20031210; AU 2003300896 A 20031210; CA 2529694 A 20031210; EP 03819151 A 20031210; EP 09169287 A 20031210; IL 17253305 A 20051213; JP 2005512414 A 20031210; MX PA06000176 A 20031210